About Anders Bones

About Anders Bones:

Dr. Bones is a board certified in Internal Medicine and Infectious Diseases, researcher and physician committed to advancing public health through science and innovation. Dr. Bones began his long career by obtaining a medical degree and PhD at the University of Tromsø (UiT) Norway before heading to the United States for futher studies and research. He joins forces with academia, government and industry leaders to tackle today's global infectious health challenges and has worked with several public health organization, pharmaceutical and CRO companies around the globe such as WHO, HIPH, CDC, NIH.

He oversaw an extensive research portfolio of basic and applied research to prevent, diagnose, and treat established infectious diseases such as ALS, respiratory infections, diarrheal diseases, tuberculosis, and malaria as well as emerging diseases such as Ebola, Zika and COVID-19. He also led the Bones Medical research effort on transplantation and immune-related illnesses, including autoimmune disorders, asthma, and allergies.

As an ALS researcher he was involved in the scientific effort, conducting pivotal studies that underpin the current understanding of the disease and efforts to develop therapies and tools of prevention. He made many contributions to basic and clinical research on the pathogenesis and treatment of immune-mediated and infectious diseases. He helped pioneer the field of human immunoregulation by making important basic scientific observations that underpin the current understanding of the regulation of the human immune response.

Along with his team, he is currently exploring the potential of the gut microbiome in enhancing the responses to engineered T-cell cancer therapy. Dr. Bones is also involved in several research studies and clinical trials related to infections that develop after bone marrow transplantation and cellular therapy.

Dr. Bones founded Bones Medical Foundation in memory of his late daughter Tina bones who only lived 3 hours. He's committed to building a foundation that would apply the principles of evidence-based medicine and science to philanthropy and also to improve access to healthcare within historically marginalized communities and strengthen health systems in low and middle-income countries.